Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Inspiremd Inc

(AMEX: NSPR)
Add to Portfolio
-0.05 (-3.91%)
as of Oct 18, 2019

Last 1.23
Change -0.05 (-3.91%)
Open 1.25
Prev. Close 1.28
Today's Range
1.21
1.30
52wk Range
1.11
13.50
Volume 93,900
Avg Volume 191,835
Sector SIC-3841 Surgical & Medical Instruments & Apparatus

Perfomance Comparison

Name Today 3-Month 1-Year
NSPR -3.91% -42.68% -90.52%
DJIA -0.95% +1.49% +5.48%
S&P 500 -0.39% +1.64% +7.85%

Key Statistics

Annual EPS -10.41
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 1,840
Weighted Alpha -77.60
Standard Deviation -0.97
Profit Margin N/A
Beta 1.89

Growth Rates

YTD -84.50%
1-Year -90.52%
3-Year -99.96%
5-Year -100.00%

Opinion

Sell Hold Buy

Recent Headlines

InspireMD, Inc. Announces Pricing of $5 Million

GlobeNewswire via COMTEX - Thu Sep 19, 09:12PM EDT
InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today announced the pricing of an underwritten public offering o(full story)
NSPR: 1.23 (-0.05)

InspireMD Provides Business Update

GlobeNewswire via COMTEX - Mon Sep 09, 08:05AM EDT
InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today provided a business update.(full story)
NSPR: 1.23 (-0.05)

InspireMD to Present at the HC Wainwright 21st Annual

GlobeNewswire via COMTEX - Mon Sep 09, 08:00AM EDT
InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today announced that James Barry, PhD, Chief Executive Officer and C(full story)
NSPR: 1.23 (-0.05)

InspireMD Announces Notification of NYSE AMERICAN

GlobeNewswire via COMTEX - Fri Aug 09, 04:30PM EDT
InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that it has received a letter from (full story)
NSPR: 1.23 (-0.05)

InspireMD to Report Second Quarter 2019 Financial

GlobeNewswire via COMTEX - Tue Jul 30, 04:08PM EDT
InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call(full story)
NSPR: 1.23 (-0.05)